Diamyd Logo

Board & Management

Board of Directors

Anders Essen-Möller, Chairman.
Born in 1941. M.Sc. Founder of and CEO during 1996-2007 of former Diamyd Medical. Chairman of present Diamyd Medical since 2013. Chairman of former Diamyd Medical during 2007-2013. Anders Essen-Möller also founded Synectics Medical AB, which was sold to Medtronic, Inc. in 1996. Anders Essen-Möller has no significant appointments outside the Company.
Holdings in Diamyd Medical as of August 31, 2014:
958 584 A shares, 3 628 588 B shares.
Maria-Teresa Essen-Möller, Board Member.
Born in 1970. M.Sc. in Business Administration. Board member of present Diamyd Medical since 2013. Board member of former Diamyd Medical during 2009-2013. Self-employed communications consultant. Account Director at Creuna 2011-2014. Maria-Teresa Essen-Möller was head of Investor Relations and Corporate Communications in former Diamyd Medical during 1997-1999. Maria-Teresa Essen-Möller has no significant appointments outside the Company.
Holdings in Diamyd Medical as of August 31, 2014:
24 000 B shares.
Erik Nerpin, Board Member.
Born in 1961. Lawyer. Self-employed with Advokatfirman Nerpin AB. Independent of the Company and its principal owners. Board member of present Diamyd Medical since 2013. Board member of former Diamyd Medical during 2012-2013.Other assignments: Chairman of Cassandra Oil AB, Kancera AB, Niccocino Holding AB, Karessa Pharma Holding AB and WYA Holding AB. Board member of Aqeri Holding AB, Header Compression Sweden Holding AB, Igrene AB, Blasieholmen Investment Group AB, Otirol Art AB and European Resolution Capital in Sweden AB.
Holdings in Diamyd Medical as of August 31, 2014:
15 400 B shares.
Fredrik Åhlander, Board Member.
Born in 1973. MD and biologist with degrees from Lund University. Independent of the Company and its principal owners. Board member of Diamyd Medical since 2014. Fredrik Åhlander works as a physician and conducts clinical research. Fredrik Åhlander has no significant appointments outside the Company.
Holdings in Diamyd Medical as of November 30, 2014: 0

Management

Peter Zerhouni, President and CEO.
Born in 1972. M.Sc. in Biology and a B.Sc. in Economics & Business Administration from Lund University and UC Berkeley. From 1999 to 2006 Peter Zerhouni held various positions at ING Bank in Brussels and Amsterdam. CEO of present Diamyd Medical since 2013. Peter Zerhouni joined former Diamyd Medical in 2006 and was appointed CEO in 2011. Peter Zerhouni has no significant appointments outside the Company.
Holdings in Diamyd Medical as of August 31, 2014:
70 000 B shares.

Erika Hillborg, Senior Director Clinical Development.
Born in 1967. M.Sc. in Biomedicine from the Karolinska Institute in Stockholm, with a Science Journalism degree from Uppsala University. Erika Hillborg joined present Diamyd Medical in 2013 and worked for former Diamyd Medical during 2006-2013. Board member of Bullerbyn Parents Association for children with type 1 diabetes.
Holdings in Diamyd Medical as of August 31, 2014:
6 000 B shares.

Anna Styrud, Chief Financial Officer.
Born in 1961. B.Sc. in Business Administration from Uppsala University. Prior experience includes Treasurer of Vasakronan AB and various positions in finance and control at Fläkt AB and National Board of Public Building. Anna Styrud joined present Diamyd Medical in 2013 and worked for former Diamyd Medical during 2010-2013. Anna Styrud has no significant appointments outside the Company.
Holdings in Diamyd Medical as of August 31, 2014:
30 000 B shares.
Contact information
Diamyd Medical AB
Kungsgatan 29,
SE-111 56 Stockholm
Sweden
Phone: +46 8 661 00 26
Fax: + 46 8 661 63 68